drugset / Trial / NCT02061163

Contrast-Enhanced Ultrasound in Human Crohn's Disease

NCT02061163

Phase 1/2 Withdrawn University of Michigan
NaSingle-groupOpen-labelDiagnostic

Summary

To determine if contrast enhanced ultrasound (CEUS) and shear wave elastography can accurately diagnose bowel wall inflammation and fibrosis in patients with known Crohn's disease.

Timeline

Start
2015-02
Primary completion
2017-01
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Background Optison Diagnostic / imaging agent Intravenous

Indications